Hexia Technologies Co., Ltd.’s HKEX GEM Listing Application Lapsed; A Leading Automotive Test Solution Provider in Zhejiang Province
Newtimespace News: The listing application filed by Zhejiang Hexia Technologies Co., Ltd. with HKEX GEM on 10 February 2026 has lapsed after the six-month validity period expired. Golden Link Capital served as the original sole sponsor.
Founded in 2017 and headquartered in Zhejiang Province, the Company has grown into the province’s leading automotive test solution provider according to Frost & Sullivan reports, partnering with a large number of top domestic and international automakers and component suppliers during the track record period. Its business is divided into three segments: automotive testing, test system integration and auto component sales, which play a vital role in the R&D of new internal combustion engine vehicles, new energy vehicles and their spare parts.
Since 2022, the Company has expanded its automotive testing service scope to ADAS testing. Meanwhile, its business has expanded to test system integration solutions and sales of auto components including urea pumps, TCUs, range-extender systems and range-extender controllers. The Company’s core testing facilities are located at its Changxing headquarters, with strategically deployed testing bases across Zhejiang, Hubei, Jiangsu, Guangdong and Shanghai, equipped with more than 430 major testing machines and devices.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HEXIA Technologies files for listing on HKEX GEM: 0.9% share of China's automotive testing solutions market by 2025 revenue
- Biotech Index Hits a Year-to-Date High as Innovative Drug and CXO Names Rally; CSOP Hang Seng Biotech ETF (3174.HK) Gains 3.18% and Is Up 17.93% Year-to-Date
- Korean Stocks Open Higher but Close Lower as Semiconductor Heavyweights Slip; Csop Kospi 200 Etf (03121.HK) Falls 1.30%
- AOM INT'L (00381.HK): Launches Twelve Dynasties Wine Project Combining Cultural Export and Digital Assets
- KINETIC DEV (01277.HK): Sierra Leone Rutile Project Commences Production